241 related articles for article (PubMed ID: 2873213)
1. Cyclic GMP as mediator and biological marker of atrial natriuretic factor.
Hamet P; Tremblay J; Pang SC; Skuherska R; Schiffrin EL; Garcia R; Cantin M; Genest J; Palmour R; Ervin FR
J Hypertens Suppl; 1986 Jun; 4(2):S49-56. PubMed ID: 2873213
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats.
Willenbrock RC; Tremblay J; Garcia R; Hamet P
J Clin Invest; 1989 Feb; 83(2):482-9. PubMed ID: 2536399
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
Leitman DC; Murad F
Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
[TBL] [Abstract][Full Text] [Related]
4. Cellular mechanisms of action of atrial natriuretic factor.
Gerzer R; Heim JM; Schütte B; Weil J
Klin Wochenschr; 1987; 65 Suppl 8():109-14. PubMed ID: 2885440
[TBL] [Abstract][Full Text] [Related]
5. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
Drewett JG; Ziegler RJ; Trachte GJ
J Pharmacol Exp Ther; 1992 Feb; 260(2):689-96. PubMed ID: 1346640
[TBL] [Abstract][Full Text] [Related]
6. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.
Tremblay J; Huot C; Willenbrock RC; Bayard F; Gossard F; Fujio N; Koch C; Kuchel O; Debinski W; Hamet P
J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238
[TBL] [Abstract][Full Text] [Related]
7. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
Murad F; Waldman S; Molina C; Bennett B; Leitman D
Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
[TBL] [Abstract][Full Text] [Related]
8. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors.
Cahill PA; Hassid A
J Cell Physiol; 1993 Jan; 154(1):28-38. PubMed ID: 7678266
[TBL] [Abstract][Full Text] [Related]
9. A functional parameter to study heterogeneity of glial cells in rat brain slices: cyclic guanosine monophosphate production in atrial natriuretic factor (ANF)-responsive cells.
De Vente J; Manshanden CG; Sikking RA; Ramaekers FC; Steinbusch HW
Glia; 1990; 3(1):43-54. PubMed ID: 2155874
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of action of atrial natriuretic factor: clinical consequences.
Gerzer R; Weil J; Strom T; Müller T
Klin Wochenschr; 1986; 64 Suppl 6():21-6. PubMed ID: 2879064
[TBL] [Abstract][Full Text] [Related]
11. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway.
Babiker FA; De Windt LJ; van Eickels M; Thijssen V; Bronsaer RJ; Grohé C; van Bilsen M; Doevendans PA
Circulation; 2004 Jan; 109(2):269-76. PubMed ID: 14718400
[TBL] [Abstract][Full Text] [Related]
12. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
[TBL] [Abstract][Full Text] [Related]
13. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
Cusson JR; Hamet P; Gutkowska J; Kuchel O; Genest J; Cantin M; Larochelle P
J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
[TBL] [Abstract][Full Text] [Related]
14. Biochemical mechanisms of atrial natriuretic factor action.
Tremblay J; Hamet P
Can J Physiol Pharmacol; 1989 Sep; 67(9):1124-9. PubMed ID: 2574629
[TBL] [Abstract][Full Text] [Related]
15. [Homologous and heterologous regulation of atrial natriuretic factor receptors in smooth muscle cells].
Chabrier PE; Roubert P; Braquet P
Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1249-51. PubMed ID: 2554838
[TBL] [Abstract][Full Text] [Related]
16. cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue.
Papapetropoulos A; Cziraki A; Rubin JW; Stone CD; Catravas JD
J Cell Physiol; 1996 May; 167(2):213-21. PubMed ID: 8613461
[TBL] [Abstract][Full Text] [Related]
17. Is cyclic GMP a clinically useful marker for ANF action?
Heim JM; Gottmann K; Weil J; Haufe MC; Gerzer R
Z Kardiol; 1988; 77 Suppl 2():41-6. PubMed ID: 2841815
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic factor (ANF) inhibits arginine vasopressin-stimulated Ca2+ fluxes and cell contraction in vascular smooth muscle cells.
Meyer-Lehnert H; Tsai P; Schrier RW
Klin Wochenschr; 1987; 65 Suppl 8():115-21. PubMed ID: 3037182
[TBL] [Abstract][Full Text] [Related]
19. Effects of atrial natriuretic factor on renal function and cyclic GMP production.
Blaine EH; Seymour AA; Marsh EA; Napier MA
Fed Proc; 1986 Jun; 45(7):2122-7. PubMed ID: 2872085
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic factor, the kidney and high blood pressure.
Hamet P; Tremblay J
Clin Invest Med; 1989 Oct; 12(5):329-35. PubMed ID: 2532087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
